Australia's Clarity Pharmaceuticals hits 3-1/2 week high on nanobody platform buy

Clarity Pharmaceuticals

31/05/2022 03:49

** Shares of Clarity Pharmaceuticals  CU6.AX  up as much as
7.6% to A$0.495, their highest since May 6 
    ** Radio-pharmaceuticals co says it acquired a targeted
nanobody platform from nanotechnology researcher Kurt Gehlsen
 urn:newsml:reuters.com:*:nASX50sgMr
    ** Says the platform's intellectual property includes a
provisional patent
    ** CU6 says by using the platform, they aim to kill cancer
cells while limiting the side effects elsewhere in the body     
    ** More than 340,000 shares change hands, vs the 30-day
average volume of ~200,000 shares
    ** Stock down 37.8% this year, as of last close
    
    

 (Reporting by Harish Sridharan in Bengaluru)
 ((harish.sridharan@thomsonreuters.com))